𝔖 Bobbio Scriptorium
✦   LIBER   ✦

METABOLIC BONE ASSESSMENT FOLLOWING ADALIMUMAB TREATMENT IN CROHN'S DISEASE

✍ Scribed by Daniel Sánchez-Cano; Ricardo Ruiz-Villaverde; Carmen Olvera-Porcel; José Luis Callejas-Rubio; Carlos Cardeña; María Gómez; Blanca Martinez-Lopez; Jorge González-Calvin; Norberto Ortego

Book ID
117646534
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
65 KB
Volume
22
Category
Article
ISSN
0953-6205

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for metabolic bone disease
Risk factors for metabolic bone disease in Crohn's disease patients
✍ Marília Cravo; Catarina Sousa Guerreiro; Paula Moura dos Santos; Miguel Brito; P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Background: The aim was to evaluate the presence of metabolic bone disease (MBD) in patients with Crohn's disease (CD) and to identify potential etiologic factors. ## Methods: The case-control study included 99 patients with CD and 56 controls with a similar age and gender distribution. Both